NKD2 and neoplasm: Interestingly, while in vitro experiments demonstrated that NKD2 knockdown significantly promoted EMT and tumour cell proliferation, the in vivo xenograft model revealed no significant difference in tumour volume between the Sh‐NKD2 and OE‐IFIX groups.